Peter Chiraseveenuprapund
No Rating Available
(Learn About Our Rating System)

Peter Chiraseveenuprapund, MD, MS

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Primary Children's Hospital

100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Eccles Primary Children's Outpatient Services Building

Pediatric Rheumatology
81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Dr. Peter Chira received his medical degree from Albert Einstein College of Medicine. He completed his pediatrics internship at Children’s National Medical Center, his pediatrics residency at Children’s Hospital Oakland (now UCSF Benioff Children’s Hospital Oakland), and his clinical fellowship in pediatric rheumatology at Stanford University/Lucile Packard Children’s Hospital. He is a Clinical Professor in the Division of Pediatric Rheumatology at the University of Utah and Primary Children’s Hospital. He is an elected member of the Childhood Arthritis and Rheumatology Research Alliance leadership and serves as Chair of the Cross Cutting Research Committee.

As a pediatric rheumatologist, he cares for all forms of childhood-onset rheumatic conditions including juvenile idiopathic arthritis, systemic lupus erythematosus, scleroderma, systemic vasculitis, dermatomyositis, as well as autoinflammatory diseases. His research focuses on transition of care from pediatric to adult healthcare systems, improving patient experiences with clinical care and research participation, and addressing health inequalities.

Specialties

Board Certification

National Board of Medical Examiners
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Peds Rheumatology)

Dr. Peter Chira received his medical degree from Albert Einstein College of Medicine. He completed his pediatrics internship at Children’s National Medical Center, his pediatrics residency at Children’s Hospital Oakland (now UCSF Benioff Children’s Hospital Oakland), and his clinical fellowship in pediatric rheumatology at Stanford University/Lucile Packard Children’s Hospital. He is a Clinical Professor in the Division of Pediatric Rheumatology at the University of Utah and Primary Children’s Hospital. He is an elected member of the Childhood Arthritis and Rheumatology Research Alliance leadership and serves as Chair of the Cross Cutting Research Committee.

As a pediatric rheumatologist, he cares for all forms of childhood-onset rheumatic conditions including juvenile idiopathic arthritis, systemic lupus erythematosus, scleroderma, systemic vasculitis, dermatomyositis, as well as autoinflammatory diseases. His research focuses on transition of care from pediatric to adult healthcare systems, improving patient experiences with clinical care and research participation, and addressing health inequalities.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor (Clinical)
Board Certification
National Board of Medical Examiners
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Peds Rheumatology)

Education history

Undergraduate Studio Art and Biology - Wesleyan University B.A.
Professional Medical Medicine - Albert Einstein College of Medicine M.D.
Internship Pediatrics - Children¿s National Medical Center, George Washington University School of Medicine Intern
Residency Pediatrics - Children's Hospital Oakland Resident
Fellowship Pediatric Rheumatology - Lucile Packard Children¿s Hospital, Stanford University School of Medicine Fellow
Graduate Training Health Services Research - Stanford University School of Medicine M.S.

Selected Publications

Journal Article

  1. Ruperto N, Lovell DJ, Synoverska O, Abud-Mendoza C, Spindler A, Vyzhga Y, Reyhan I, Grebenkina L, Tirosh I, Imundo L, Chiraseveenuprapund P, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Roberts KD, Sawyerr G, Blum A, Shapiro A, Diehl A, Ebrahim A, Klaus P, Martini A, Brunner HI, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG (2025). Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial. ACR open rheumatology, 7(10), e70097.
  2. Brunner HI, Alexeeva E, Bandeira M, Carrasco R, Chaitow J, Chiraseveenuprapund P, Ting TV, Erguven M, Gottlieb B, Oliveira SK, Patel PN, Ozen S, Saad Magalhaes C, Penadés IC, Gruben D, Germino R, Posner HB, Stockert L, Martini A, Lovell DJ, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG (2025). Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial. Arthritis & rheumatology (Hoboken, N.J.),
  3. Stubbs LA, Ferry AM, Guffey D, Loccke C, Wade EM, Pour P, Ardalan K, Chira P, Ganske IM, Glaser D, Higgins G, Luca N, Moore KF, Sivaraman V, Stewart K, Vasquez-Canizares N, Hunt RD, Maricevich RS, Torok KS, Li SC, Childhood Arthritis, Rheumatology Research Alliance (CARRA) Scleroderma Workgrou (2023). Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives. Pediatric rheumatology online journal, 21(1), 39.
  4. Carandang K, Wells CK, Guglielmo D, Melcher K, Trimble M, Ardoin SP, Chira P (2022). Adolescents' and Young Adults' Recommendations for Implementing Healthcare Transition in Rheumatology: A Mixed Methods Study.(Epub ahead of print). Arthritis Care Res (Hoboken).
  5. Yildirim-Toruner C, Pooni R, Goh YI, Becker-Haimes E, Dearing JW, Fernandez ME, Morgan EM, Parry G, Burnham JM, Ardoin SP, Barbar-Smiley F, Chang JC, Chiraseveenuprapund P, Del Gaizo V, Eakin G, Johnson LC, Kimura Y, Knight AM, Kohlheim M, Lawson EF, Lo MS, Pan N, Ring A, Ronis T, Sadun RE, Smitherman EA, Taxter AJ, Taylor J, Vehe RK, Vora SS, Weiss JE, von Scheven E, MAS for the CARRA Implementation Science Workgroup (2022). Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat. Pediatr Rheumatol Online J, 20(1), 10.
  6. Chalhoub NE, Wenderfer SE, Levy DM, Rouster-Stevens K, Aggarwal A, Savani SI, Ruth NM, Arkachaisri T, Qiu T, Merritt A, Onel K, Goilav B, Khubchandani RP, Deng J, Fonseca AR, Ardoin SP, Ciurtin C, Kasapcopur O, Jelusic M, Huber AM, Ozen S, Klein-Gitelman MS, Appenzeller S, Cavalcanti A, Fotis L, Lim SC, Silva RM, Miramontes JR, Rosenwasser NL, Saad-Magalhaes C, Schonenberg-Meinema D, Scott C, Silva CA, Enciso S, Terreri MT, Torres-Jimenez AR, Trachana M, Al-Mayouf SM, Devarajan P, Huang B, Brunner HI, Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Work Group and the Pediatric Rheumatology European Society Lupus Working Party (2022). International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Arthritis Rheumatol, 74(2), 263-273.
  7. Johnson KR, Edens C, Sadun RE, Chira P, Hersh AO, Goh YI, Hui-Yuen J, Singer NG, Spiegel LR, Stinson JN, White PH, Lawson E, CARRA Transition Workgroup (2021). Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018. J Rheumatol, 48(9), 1442-1449.
  8. Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ, Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG) (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet, 398(10315), 1984-1996.
  9. Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2021). Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis. Arthritis care & research, 73(7), 940-946.
  10. Jones JT, Smith C, Becker ML, Lovell D, CARRA Registry Investigator (2021). Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes. Arthritis care & research, 73(12), 1739-1745.
  11. Zisman D, Samad A, Ardoin SP, Chira P, White P, Lavi I, von Scheven E, Lawson EF, Hing M, Mellins ED (2020). US Adult Rheumatologists' Perspectives on the Transition Process for Young Adults With Rheumatic Conditions. Arthritis Care Res (Hoboken), 72(3), 432-440.
  12. Connelly M, Schanberg LE, Ardoin S, Blakley M, Carrasco R, Chira P, Hayward K, Ibarra M, Kimura Y, Kingsbury DJ, Klein-Gitelman MS, Lawson E, Stinson J (2019). Multisite Randomized Clinical Trial Evaluating an Online Self-Management Program for Adolescents With Juvenile Idiopathic Arthritis. J Pediatr Psychol, 44(3), 363-374.
  13. Brunner HI, Holland MJ, Beresford MW, Ardoin SP, Appenzeller S, Silva CA, Flores F, Goilav B, Avar Aydin PO, Wenderfer SE, Levy DM, Ravelli A, Khubchandani R, Avcin T, Klein-Gitelman MS, Ruperto N, Feldman BM, Ying J, Paediatric Rheumatology International Trial Organisation and Pediatric Rheumatology Collaborative Study Grou (2019). American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Arthritis care & research, 71(5), 579-590.
  14. Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS, ARChiVe Investigators Network within the PedVas Initiativ (2016). Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis & rheumatology (Hoboken, N.J.), 68(10), 2514-26.
  15. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (CARRA) (2014). Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol, 41(6), 1163-70.
  16. Chira P, Ronis T, Ardoin S, White P (2014). Transitioning youth with rheumatic conditions: perspectives of pediatric rheumatology providers in the United States and Canada. J Rheumatol, 41(4), 768-79.
  17. Ronis T, Frankovich J, Yen S, Sandborg C, Chira P (2014). Pilot study of reproductive health counseling in a pediatric rheumatology clinic. Arthritis Care Res (Hoboken), 66(4), 631-5.
  18. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE, APPLE Investigator (2014). Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus science & medicine, 1(1), e000011.
  19. Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA, ARChiVe Investigators Network (2012). Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions. J Rheumatol, 39(10), 2012-20.
  20. Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA, ARegistry for Children with Vasculitis e-entry (ARChiVe) Network (2012). Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol, 39(8), 1687-97.
  21. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (2012). Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum, 64(6), 2012-21.
  22. Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA, ARChiVe Investigators Network (2012). Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol, 39(5), 1088-94.
  23. Stinson JN, Connelly M, Jibb LA, Schanberg LE, Walco G, Spiegel LR, Tse SM, Chalom EC, Chira P, Rapoff M (2012). Developing a standardized approach to the assessment of pain in children and youth presenting to pediatric rheumatology providers: a Delphi survey and consensus conference process followed by feasibility testing. Pediatr Rheumatol Online J, 10(1), 7.
  24. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Provenzale J, Thompson SD, Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigator (2012). Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis and rheumatism, 64(1), 285-96.
  25. Chira P, Nugent L, Miller K, Park T, Donahue S, Soni A, Nugent D, Sandborg C (2010). Living Profiles: design of a health media platform for teens with special healthcare needs. J Biomed Inform, 43(5 Suppl), S9-S12.
  26. Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski Kl, Ilowite NT, von Scheven E, Eberhard A, Levy DM, Kimura Y, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung LK, Imundo L, Soep JB, Reed AM, APPLE investigator (2010). Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus, 19(11), 1315-25.
  27. Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A, ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network (2009). Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum, 60(11), 3413-24.
  28. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed A, Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigator (2009). Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis and rheumatism, 60(5), 1496-507.
  29. Yuen CC, Burton W, Chiraseveenuprapund P, Elmore E, Wong S, Ozuah P, Mulvihill M (1998). Attitudes and beliefs about organ donation among different racial groups. J Natl Med Assoc, 90(1), 13-8.

Review

  1. Bitencourt N, Lawson E, Bridges J, Carandang K, Chintagunta E, Chiraseveenuprapund P, DeQuattro K, Goh YI, Lee TC, Moore KF, Peterson RG, Roberts JE, Ronis T, Sadun RE, Smitherman EA, Stringer E, White PH, Chang JC, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Transition Workgroup (2022). Pediatric to Adult Transition Literature: Scoping Review and Rheumatology Research Prioritization Survey Results. [Review]. J Rheumatol, 49, (11), 1201-1213.
  2. Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB, Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigator (2015). Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediatric rheumatology online journal, 13, 13.
  3. Chira P, Sandborg CI (2003). Novel therapies in pediatric rheumatic diseases. [Review]. Curr Opin Pediatr, 15, (6), 579-85.

Editorial

  1. Chira P, Sandborg C (2004). Adolescent rheumatology transitional care: steps to bringing health policy into practice. Rheumatology (Oxford), 43(6), 687-9.

Letter

  1. Chira P (2015). Dr. Chira replies. [Letter to the editor]. J Rheumatol, 42(5), 903.